PDF herunterladen
Fortschr Neurol Psychiatr 2018; 86(05): 279-286
DOI: 10.1055/a-0576-6950
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Status epilepticus

Status epilepticus
Lothar Burghaus
1   Heilig Geist-Krankenhaus Köln, Klinik für Neurologie
2   Uniklinik Köln, Klinik und Poliklinik für Neurologie
,
Christian Dohmen
3   LVR-Klinik Bonn, Neurologie
,
Michael Malter
2   Uniklinik Köln, Klinik und Poliklinik für Neurologie
› Institutsangaben
Weitere Informationen

Publikationsverlauf

eingereicht 01. Dezember 2017

akzeptiert 03. Februar 2018

Publikationsdatum:
29. Mai 2018 (online)

    Lizenzen und Reprints

Zusammenfassung

Der Status epilepticus ist ein neurologischer Notfall, der durch prolongierte Anfallsaktivität oder eine Serie von Anfällen ohne zwischenzeitliche Wiedererlangung des vorbestehenden neurologischen Befundes gekennzeichnet ist. Vorrangiges Ziel der Therapie ist die rasche Beendigung der Anfälle, da mit zunehmender Dauer des Status epilepticus Morbidität und Mortalität ansteigen. Auf der Grundlage von klinischen Studien und Leitlinienempfehlungen werden Strategien zur Behandlung des Status epilepticus vorgestellt.

Abstract

Status epilepticus is a neurologic emergency manifested by prolonged seizure activity or multiple seizures without full recovery of previous condition in between. The most important aim of treatment is early seizure termination, because duration of status epilepticus correlates with a higher rate of morbidity and mortality. Based on evidence from clinical trials and guidelines strategies for management of status epilepticus are provided.

Schlüsselwörter

Neurologische Notfallmedizin - Status epilepticus - antikonvulsive Therapie

Key words

neurologic emergency - status epilepticus - anticonvulsant therapy
 

  • Literatur

  • 1 Knake S, Rosenow F, Vescovi M. et al. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 2001; 42: 714-718
    CrossrefPubMedGoogle Scholar
  • 2 Trinka E, Cock H, Hesdorffer D. et al. A definition and classification of status epilepticus–Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia 2015; 56: 1515-1523
    CrossrefPubMedGoogle Scholar
  • 3 Chen JW, Wasterlain CG. Status epilepticus: pathophysiology and management in adults. Lancet Neurol 2006; 5: 246-256
    CrossrefPubMedGoogle Scholar
  • 4 Lowenstein DH, Bleck T, Macdonald RL. It’s time to revise the definition of status epilepticus. Epilepsia 1999; 40: 120-122
    CrossrefPubMedGoogle Scholar
  • 5 Specht U, Elsner H, May TW. et al. Postictal serum levels of antiepileptic drugs for detection of noncompliance. Epilepsy Behav 2003; 4: 487-495
    CrossrefPubMedGoogle Scholar
  • 6 Gaspard N, Foreman BP, Alvarez V. et al. Critical Care EEG Monitoring Research Consortium (CCEMRC). New-onset refractory status epilepticus: Etiology, clinical features, and outcome. Neurology. 2015; 85 (18) ; 1604-1613
    PubMedGoogle Scholar
  • 7 Sundararajan T, Tesar GE, Jimenez XF. Biomarkers in the diagnosis and study of psychogenic nonepileptic seizures: A systematic review. Seizure 2016; 35: 11-22
    CrossrefPubMedGoogle Scholar
  • 8 Holtkamp M, Othman J, Buchheim K. et al. Diagnosis of psychogenic nonepileptic status epilepticus in the emergency setting. Neurology 2006; 13 (66) 1727-1729
    PubMedGoogle Scholar
  • 9 LaFrance WC, Reuber M, Goldstein LH. Management of psychogenic nonepileptic seizures. Epilepsia 2013; 54 (Suppl 1): 53-67
    CrossrefPubMedGoogle Scholar
  • 10 Trinka E, Höfler J, Leitinger M. et al. Pharmacologic treatment of status epilepticus. Expert Opin Pharmacother 2016; 17: 513-534
    CrossrefPubMedGoogle Scholar
  • 11 Alldredge BK, Gelb AM, Isaacs SM. et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001; 345: 631-637
    CrossrefPubMedGoogle Scholar
  • 12 Leppik IE, Derivan AT, Homan RW. et al. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 1983; 249: 1452-1454
    CrossrefPubMedGoogle Scholar
  • 13 Silbergleit R, Durkalski V, Lowenstein D. et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012; 366: 591-600
    CrossrefPubMedGoogle Scholar
  • 14 Arya R, Kothari H, Zhang Z. et al. Efficacy of nonvenousmedications for acute convulsive seizures: A network meta-analysis. Neurology . 2015; 24 (85) 1859-1868
    PubMedGoogle Scholar
  • 15 Treiman DM, Meyers PD, Walton NY. et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998; 17 (339) 792-798 .
    PubMedGoogle Scholar
  • 16 Navarro V, Dagron C, Elie C. et al. Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial. Lancet Neurol 2016; 15: 47-55
    CrossrefPubMedGoogle Scholar
  • 17 Glauser T, Shinnar S, Gloss D. et al. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr 2016; 16: 48-61
    CrossrefPubMedGoogle Scholar
  • 18 Moreno Morales EY, Fernandez Peleteiro M, Bondy Peña EC. et al. Observational study of intravenous lacosamide in patients with convulsive versus non-convulsive status epilepticus. Clin Drug Investig 2015; 35: 463-469
    CrossrefPubMedGoogle Scholar
  • 19 Höfler J, Trinka E. Lacosamide as a new treatment option in status epilepticus. Epilepsia 2013; 54: 393-404
    CrossrefPubMedGoogle Scholar
  • 20 Strzelczyk A, Steinig I, Willems LM. et al. Treatment of refractory and super-refractory status epilepticus with brivaracetam: A cohort study from two German university hospitals Epilepsy Behav.. 2017; 70: 177-181
    PubMedGoogle Scholar
  • 21 Agarwal P, Kumar N, Chandra R. et al. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 2007; 16: 527-532
    CrossrefPubMedGoogle Scholar
  • 22 Misra UK, Kalita J, Matuszczak J, Maurya PK. Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study. J Neurol 2012; 259: 645-648
    CrossrefPubMedGoogle Scholar
  • 23 Mundlamuri RC, Sinha S, Subbakrishna DK. et al. Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam–Pilot study. Epilepsy Res 2015; 114: 52-58
    CrossrefPubMedGoogle Scholar
  • 24 Chakravarthi S, Goyal MK, Modi M. et al. Levetiracetam versus phenytoin in management of status epilepticus. J Clin Neurosci 2015; 22: 959-963
    CrossrefPubMedGoogle Scholar
  • 25 Yasiry Z, Shorvon SD. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies. Seizure. 2014 23. 167-174
    PubMedGoogle Scholar
  • 26 Cock HR; ESETT Group. . Established status epilepticus treatment trial (ESETT). Epilepsia . 2011; 52 (Suppl 8 ): 50-52
    PubMedGoogle Scholar
  • 27 Ferlisi M, Shorvon S. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain 2012; 135: 2314-2328
    CrossrefPubMedGoogle Scholar
  • 28 Fernandez A, Lantigua H, Lesch C. et al. High-dose midazolam infusion for refractory status epilepticus. Neurology 2014; 82: 359-365
    CrossrefPubMedGoogle Scholar
  • 29 Rossetti AO, Milligan TA, Vulliémoz S. et al. A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care . 2011; 14: 4-10
    CrossrefPubMedGoogle Scholar
  • 30 Vohra TT, Miller JB, Nicholas KS. et al. Neurological Emergencies Treatment Trials (NETT) Investigators. Endotracheal Intubation in Patients Treated for Prehospital Status Epilepticus. Neurocrit Care. 2015; 23: 33-43
    PubMedGoogle Scholar
  • 31 Gao Q, Ou-Yang TP, Sun XL. et al. Prediction of functional outcome in patients with convulsive status epilepticus: the END-IT score. Crit Care . 2016; 20: 46
    CrossrefPubMedGoogle Scholar
  • 32 Brophy GM, Bell R, Claassen J. et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012; 17: 3-23
    CrossrefPubMedGoogle Scholar
  • 33 Höfler J, Rohracher A, Kalss G. et al. (S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study. CNS Drugs . 2016; 30: 869-876
    CrossrefPubMedGoogle Scholar
  • 34 Duley L, Gülmezoglu AM, Henderson-Smart DJ. et al. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2010 :CD000025.
    PubMed
  • 35 Zeiler FA, Zeiler KJ, Teitelbaum J. et al. Modern inhalational anesthetics for refractory status epilepticus. Can J Neurol Sci 2015; 42: 106-115
    CrossrefPubMedGoogle Scholar
  • 36 Zeiler FA, Zeiler KJ, Kazina CJ. et al. Lidocaine for status epilepticus in adults. Seizure 2015; 31: 41-48
    CrossrefPubMedGoogle Scholar
  • 37 Holzer FJ, Seeck M, Korff CM. Autoimmunity and inflammation in status epilepticus: from concepts to therapies. Expert Rev Neurother 2014; 14: 1181-1202
    CrossrefPubMedGoogle Scholar
  • 38 Waterhouse FA, Matuszczak EJ. The epidemiology of nonconvulsive status epilepticus. In: Kaplan PW, Drislane FW. editors. Nonconvulsive Status Epilepticus. New York (NY): Demos Medical Publishing; 2009: 23-39
    Google Scholar
  • 39 Fernández-Torre JL, Kaplan PW, Hernández-Hernández MA. New understanding of nonconvulsive status epilepticus in adults: treatments and challenges. Expert Rev of Neurother 2015; 15: 1455-1473
    PubMedGoogle Scholar
  • 40 Shorvon S, Walker M. Status epilepticus in idiopathic generalized epilepsy. Epilepsia 2005; 46 (Suppl 9): 73-79
    PubMedGoogle Scholar
  • 41 Rosenow F, Knake S. Recent and future advances in the treatment of status epilepticus. Ther Adv Neurol Disord 2008; 1: 33-42
    CrossrefPubMedGoogle Scholar
  • 42 McDonald TJW, Cervenka MC. Ketogenic Diets for Adults With Highly Refractory Epilepsy. Epilepsy Curr 2017; 17: 346-50
    CrossrefPubMedGoogle Scholar
  • 43 Strzelczyk A, Reif PS, Bauer S. et al. Intravenous initiation and maintenance of ketogenic diet: Proof of concept in super-refractory status epilepticus, Seizure 2013; 22: 581-583
    PubMed
  • 44 Legriel S, Lemiale V, Schenck M. et al. Hypothermia for Neuroprotection in Convulsive Status Epilepticus. N Engl J Med . 2016; 375: 2457-2467
    CrossrefPubMedGoogle Scholar
  • 45 Zeiler FA, Matuszczak M, Teitelbaum J. et al. Electroconvulsive therapy for refractory status epilepticus: A systematic review. Seizure 2016; 35: 23-32
    CrossrefPubMedGoogle Scholar
  • 46 McGinity M, Andrade FA, Matuszczak N, Karkar K. , et al. Functional Hemispherectomy for Refractory Status Epilepticus in 2 Adults. World Neurosurg 2016; 93: 489.e11-6
    PubMedGoogle Scholar